Didier Laurent

机构：Novartis (Switzerland), Novartis Foundation · ORCID：0000-0002-4507-1334

发表论文 136 篇 · 总被引 7540 次 · h-index 39

代表论文

• Angiopoietin-like 3-derivative LNA043 for cartilage regeneration in osteoarthritis: a randomized phase 1 trial (2022 · Nature Medicine · 被引 63)
• A decision-support framework for the restoration of Cystoseira sensu lato forests (2023 · Frontiers in Marine Science · 被引 30)
• Longitudinal Changes in MRI Muscle Morphometry and Composition in People With Inclusion Body Myositis (2022 · Neurology · 被引 29)
• Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338) (2022 · Clinical Pharmacokinetics · 被引 18)
• POS0277 ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS (2021 · Annals of the Rheumatic Diseases · 被引 10)
• Prognostic value of B-score for predicting joint replacement in the context of osteoarthritis phenotypes: Data from the osteoarthritis initiative (2024 · Osteoarthritis and Cartilage Open · 被引 6)